Posted by Michael Wonder on 16 Apr 2019
Drug company boss calls for inquiry over breast cancer drug prices
16 April 2019 - A drug company head says the government should hold an inquiry into the prices pharmaceutical firms charge for breast cancer drugs.
Patients battling for two new drugs had their calls for an inquiry into drug buyer PHARMAC turned down by MPs last week.
Chairperson of family-owned New Zealand pharmaceutical company Te Arai BioFarma, Lance Gravatt, lost his son Zachary, a medical student who died from meningococcal septicaemia at Auckland Hospital in 2009.
"It was a similar situation," he said. "He could have been saved by a vaccine that wasn't funded because it wasn't considered to be cost-effective."
